Nova Mentis Life Science Corp. C.LIB

Trial Results

[TenFingers]

This study meets the HC requirements (16 subjects and other parameters).  As far as I can tell, they can immediately apply for a license on this formula as they proceed to secure further formulations to treat other conditions and expand to feline studies.

This is a big card for them. 15 out of 16 subjects benefitted.  We are rounding a corner where pet owners are not going to want to purchase rogue products to treat their fur babies. They want a sanctioned formula. LIB will have it.

[TenFingers]

Also congrats to the LIB team for delivering on time and as expected. 8 months from december 20th - to the DAY. Ovy called it.

[Ovechkin]

This post has been removed in accordance with Community Policy

[Snoopydoo01]

Expected timframe again for this one? Thanks

[Ovechkin]

This post has been removed in accordance with Community Policy

[michelleb33]

dont think the news this morning did anything for the sp. The whole sector was up today

[TenFingers]

If I've learned anything about the patterns of news releases for LIB, it's that they love to fire in waves. :) It wouldn't surprise me to see this tomorrow, or this week for sure. And what about Signature? That is a wildcard right now that I'm loving.

[TenFingers]

I woud also expect a follow-up to this soon. This news release doesn't talk about WHAT, specifically, their roadmap is for this successful formulation, or if they are just going to sit on it until they can produce it themselves. It just talks about a new trial for felines. I was half expecting an announcement like this to include an application filing announcement with HC. Was a bit surprised